- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07330882
Health Behavior Management Program for Patients With Coronary Heart Disease
Health Behavior Management Program for Patients With Coronary Heart Disease: A Clinical Study
Coronary artery disease (CAD) is a major chronic condition severely impacting population health in China. Our previous cohort studies revealed a high comorbidity rate between CAD and frailty, suggesting their interrelated equivalence as clinical syndromes with shared risk factors. In recent years, pilot integrated health management initiatives in China have demonstrated promising outcomes, yet evidence remains scarce regarding patients with concurrent CAD and frailty-a critical gap needing urgent resolution to achieve the "Healthy China 2030" strategic goals.
Building on prior research, this project aims to systematically evaluate existing management models for patients with CAD and frailty, develop a tailored health management framework, and implement it in clinical settings through empirical studies. The model will be optimized according to regional and demographic variations, leveraging cardiac rehabilitation centers, exercise-based interventions, and internet-enabled technologies to enhance coordinated care. By improving exercise efficacy, mitigating frailty progression, and enhancing quality of life, this initiative seeks to establish a robust chronic disease management system. The findings will provide evidence for formulating regional health policy and insurance strategies in Anhui Province, ultimately improving standardized management rates for chronic diseases.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bengbu, China
- The First Affiliated Hospital of Bengbu Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of Coronary heart disease;
- Proficiency in smartphone use;
- Absence of visual, auditory, cognitive, or motor impairments.
Exclusion Criteria:
- Inability or unwillingness to provide informed consent;
- Physical or cognitive limitations preventing app operation;
- Inability to attend in-person follow-up visits;
- Concurrent severe comorbidities or malignancies, such as severe valvular heart disease, New York Heart Association class IV heart failure, severe aortic regurgitation, cancer, end-stage renal or liver disease;
- Any other condition that could potentially impede exercise participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
The intervention consists of two parts: Health management model: Establish a "hospital-home" full-process health management service chain based on mobile health.
Firstly, cardiac specialist nurses conduct a comprehensive assessment of each patient's cardiac rehabilitation status and implement individualized interventions.
The specific intervention procedures are: "Assess the patient's current condition and capabilities - Promote the patient's awareness of the current situation - Develop and revise the cardiac rehabilitation plan - Supervise the implementation of the cardiac rehabilitation plan."
|
The development, application and evaluation of an innovative health management model for patients with coronary heart disease and frailty based on the "cardiac rehabilitation center" framework, exercise rehabilitation, and new technologies such as "mobile health".
|
|
Active Comparator: Control group
During the patient's hospital stay and after discharge, cardiovascular internal medical staff provide them with routine medical,nursing services and health education.
In terms of basic drug treatment, the principles of secondary prevention for coronary heart disease should be followed.
Routine nursing care and health education were delivered through verbal instruction and the "317 Nursing Education Platform."
They were also advised to maintain a healthy lifestyle and participate in appropriate physical activities.
|
The development, application and evaluation of an innovative health management model for patients with coronary heart disease and frailty based on the "cardiac rehabilitation center" framework, exercise rehabilitation, and new technologies such as "mobile health".
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6MWD
Time Frame: 1month,3 months, 6 months
|
Measuring the maximum distance within 6 minutes.
|
1month,3 months, 6 months
|
|
The MOS item short from health survey
Time Frame: 1month,3 months, 6 months
|
Quality of life was assessed using the 36-Item Short Form Health Survey questionnaire
|
1month,3 months, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frailty
Time Frame: 1month,3 months, 6 months
|
The FRAIL Scale
|
1month,3 months, 6 months
|
|
Grip strength
Time Frame: 1month,3 months, 6 months
|
Electronic grip device
|
1month,3 months, 6 months
|
|
Gait speed
Time Frame: 1month,3 months, 6 months
|
Stopwatch
|
1month,3 months, 6 months
|
|
Physical activity level
Time Frame: 1month,3 months, 6 months
|
The short version self-reported International Physical Activity Questionnaire.
|
1month,3 months, 6 months
|
|
Systolic pressure/Diastolic pressure
Time Frame: 1month,3 months, 6 months
|
Calibrated electronic blood pressure monitor
|
1month,3 months, 6 months
|
|
Major cardiovascular adverse events
Time Frame: 1month,3 months, 6 months
|
Major Adverse Cardiovascular Events (MACE) were defined as at least one of the following: heart failure, malignant arrhythmia, recurrent angina, recurrent myocardial infarction, cardiogenic shock, cardiac arrest, or sudden cardiac death.
|
1month,3 months, 6 months
|
|
Changes in Blood Lipid Biomarkers
Time Frame: 1 month, 3 months, 6 months
|
Changes in blood lipid biomarkers, including triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), were assessed.
|
1 month, 3 months, 6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Tong Zhou, The First Affiliated Hospital of Bengbu Medical University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FirstAHBBMC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Disease
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
OPCI Core Laboratories LLCNot yet recruitingCoronary Artery Disease (CAD) | Coronary Calcification | Coronary Calcified Disease | Coronary Calcified NodulesUnited States
-
Shunmei MedicalNot yet recruitingCalcified Coronary Artery Disease | Coronary Arterial DiseasePoland, France, Spain
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Percutaneous Coronary Intervention | Coronary Stenosis | Coronary Restenosis | Coronary Artery Disease Progression | Coronary Stent Occlusion | Myocardial Revascularization
-
SUK MIN SEODaewoong Pharmaceutical Co. LTD.RecruitingCoronary Artery Disease (CAD) | Acute Coronary Syndromes (ACS)South Korea
-
Olivier F. BertrandRecruitingBifurcation Coronary Disease | Restenosis, Coronary | Coronary Arterial Disease (CAD)Canada
-
Ceric SàrlEuropean Cardiovascular Research Center; Philips Medical SystemsNot yet recruitingStable Coronary Artery Disease | Acute Coronary Syndromes
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaTerminatedCoronary Stenosis | Coronary Artery Bypass Grafting | Coronary Artery Disease Progression | Percutaneous Coronary RevascularizationSouth Korea
-
Cardiocentro TicinoNot yet recruitingMultivessel Coronary Artery Disease | Coronary Vessel | Acute Coronary Syndromes (ACS) | Vulnerable Coronary Plaques | Coronary Arterial Disease (CAD)Switzerland
Clinical Trials on Exercise rehabilitation plan and health management model for patients with coronary heart disease and frailty based on mobile health technology
-
Yuzuncu Yil UniversityCompletedSurgery (Cardiac)Turkey (Türkiye)
-
Madeleine BezaultRecruiting
-
Mayo ClinicCompletedMalignant Solid Neoplasm | Lymphoma | Multiple Myeloma | Hematopoietic and Lymphoid System Neoplasm | Chronic LeukemiaUnited States
-
Norwegian Institute of Public HealthUniversity of Oslo; Oslo University Hospital; Oslo MunicipalityActive, not recruitingHip Fractures | Fall Injury